- STAT+: Anthropic deepens work with rare disease drugsNovo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The ReadoutSTAT · 3d ago↗ source
- STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreNovo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effectiveSTAT · 3d ago↗ source
- ‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx dealFor years, as Big Pharma poured billions into ADCs, Novartis CEO Vas Narasimhan notably stayed on the sidelines. Asked by Fierce during Novartis’ Q2 earnings call, Narasimhan explained why he is en…